In Vitro Equinos
- Company typePrivate
- Founded2005
- HeadquartersMogi Mirim, Brazil
- Headcount11–50
- GTM typeB2B
- OfferingServices
In Vitro Equinos firmographics
Firmographics- Name
- In Vitro Equinos
- Legal name
- In Vitro Equinos Ltda.
- Website
- https://invitroequinos.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
In Vitro Equinos industry classification
Industry- Product category
- Equine Reproductive Biotechnology Services
- NAICS
- Veterinary Services (54194), Support Activities for Animal Production (11521)
- SIC
- Agricultural Services (700), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Reproduction, Breeding & Theriogenology (Large Animal/Equine) (HLAMABAG)
Keywords
Where In Vitro Equinos is headquartered
LocationHeadquarters
- HQ city
- Mogi Mirim
- HQ country
- Brazil
- HQ region
- Latin America
Offices4 records
Markets served
In Vitro Equinos business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- ICSI Services: In vitro embryo production service involving follicular aspiration, laboratory embryo production, vitrification, and transfer consultation. Priced per aspiration procedure with additional costs for embryo production and cryopreservation.
- Equine Cloning: Complete cloning service from skin biopsy collection through cell line establishment, nuclear transfer, embryo production, and transfer to recipient mares.
- Genetic Bank: Cell preservation service storing animal cells in liquid nitrogen for future cloning use, with annual storage fees.
- Embryo Biopsy: Genetic sex identification service for embryos prior to transfer, enabling strategic breeding decisions.
- Semen Sexing: Sperm separation service producing sexed semen for use in ICSI procedures, allowing foal sex selection.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom service packages based on individual client requirements |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
In Vitro Equinos product offering
Product offeringCore offering
In Vitro Equinos provides advanced equine reproductive biotechnology services for horse breeders and veterinarians, with ICSI (Intracytoplasmic Sperm Injection) as the central commercial offering, complemented by equine cloning via nuclear transfer, genetic banking (cell cryopreservation), embryo biopsy for sex identification, and semen sexing. Services are delivered through a field-and-laboratory model with specialized OPU teams operating on client stud farms and centralized laboratories producing, cryopreserving, and transferring embryos, supported by a proprietary mobile application for real-time client monitoring.
Product overview
In Vitro Equinos is a biotechnology company offering a suite of equine reproductive services centered on ICSI (Intracytoplasmic Sperm Injection) as the core technology. The portfolio includes Clonagem Animal (Equine Cloning) for producing genetically identical organisms, Banco Genético (Genetic Bank) for cell preservation in liquid nitrogen, and add-on services like Biópsia Embrionária (Embryo Biopsy) for pre-transfer sex identification and Sexagem de Sêmen (Semen Sexing) for offspring sex selection. The company also provides a proprietary mobile application for real-time monitoring of embryo production, results tracking, and herd performance analytics.
Differentiator
Problem solved
Functional benefit
Products and services
- ICSI (Intracytoplasmic Sperm Injection) Intracytoplasmic Sperm Injection technique developed and commercially applied for in vitro equine embryo production, involving follicular aspiration (OPU), laboratory embryo production (maturation, ICSI, in vitro culture), embryo vitrification, and transfer to recipient mares. Designed for horse breeders and veterinarians seeking to maximize offspring from genetically superior mares and stallions.
- Equine Cloning (Clonagem Animal) Production of genetically identical horses through nuclear transfer, where a skin biopsy is collected and cultivated to obtain cell lines used as genetic source for cloned embryos transferred to recipient mares. Serves breeders seeking to replicate elite animals.
- Genetic Bank (Banco Genético) Preservation of animal cells frozen in liquid nitrogen for future use in cloning, with up to 6 hours post-mortem collection window for emergency situations. Includes annual storage fees for ongoing cell preservation.
- Embryo Biopsy (Biópsia Embrionária) Technique that analyzes embryo genetic material to identify sex prior to transfer without compromising gestational development viability. Serves breeders aiming to make strategic sex selection decisions before transfer.
- Semen Sexing (Sexagem de Sêmen) Laboratory process to separate X-chromosome-bearing sperm from Y-chromosome-bearing sperm with up to 90% accuracy, allowing sex selection of foals before ICSI. Serves breeders seeking to predetermine foal sex for strategic breeding programs.
- In Vitro Equinos Mobile Application Customer-facing mobile application for real-time monitoring of embryo production results, frozen embryo stock, pregnancy diagnosis updates, and donor conversion rate tracking. Allows clients to track each stage of embryo production and compare donor performance versus overall results.
Quantifiable outcome
- 2 embryos per aspiration average production in 2024
- +5 more outcomes
Companies that use In Vitro Equinos
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
In Vitro Equinos technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
In Vitro Equinos partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Equine Care Group (ECG)flagshipStrategic partnership joining In Vitro Equinos with Equine Care Group, one of the most advanced veterinary networks worldwide dedicated to equine health. Founded in 2021 by Dr. Tom Mariën (founder of Equitom). This partnership enables growth in Europe, North America, Middle East, Australia and beyond through global infrastructure focused on quality, ethics, and innovation. Goal is to advance equine reproduction and contribute to the future of equine medicine through research, collaboration, and knowledge sharing.
Scale indicators10 records
Recent moves12 records
Expansion highlights6 records
In Vitro Equinos competitors and assessment
Company assessmentDirect peers
- Crestview Genetics: Equine ICSI and embryo transfer services provider in the United States. Directly comparable as a commercial equine ICSI and reproductive services company serving elite horse breeders, with overlapping technology stack and customer type.
- ViaGen Pets & Equine: US-based leader in animal cloning and genetic preservation services, including equine cloning and genetic banking. Directly comparable as the most prominent commercial equine cloning and genetic storage provider globally, competing for the same high-end breeder customer base.
- Stallion AI Services: UK-based equine semen collection, distribution, and artificial insemination services. Comparable in providing advanced equine reproductive services to breeders, with overlap in the genetic preservation and breeding optimization space.
Broad incumbents
- Rood & Riddle Equine Hospital: Major US equine veterinary hospital network offering reproductive services including embryo transfer and stallion services. Comparable as a large incumbent in equine veterinary services with reproductive capabilities.
- IMV Technologies: Global animal reproduction technology company offering equipment and consumables for bovine, equine, and other species AI and IVF. Comparable as a broader animal reproductive services/equipment incumbent in the same end market.
- Hamilton Thorne: Provider of precision instruments, consumables, and software for the animal breeding and reproductive sciences markets. Comparable as an enabling technology provider in the equine/artificial reproduction ecosystem, though it sells equipment rather than services.
- Hagyard Equine Medical Institute: Large US equine veterinary hospital and referral practice offering advanced reproductive services including ICSI and embryo transfer. Comparable as an established equine veterinary services provider with overlapping reproductive capabilities.
- Equine Care Group: International veterinary network founded by Dr. Tom Mariën (Equitom), focused on equine health. Now a strategic partner of In Vitro Equinos; comparable as a broader equine veterinary services platform with reproductive capabilities and global infrastructure.
Emerging players
- Equine Reproduction Laboratory (CSU): Colorado State University's equine reproduction program offering commercial ICSI and embryo services. Comparable as an academically-affiliated equine reproductive services provider with similar technology stack.
Regional players
- Goulburn Valley Equine Hospital: Australian equine veterinary hospital offering advanced reproductive services including ICSI and embryo transfer. Comparable as a regional equine reproduction specialist, though operating primarily in Australia rather than the Americas.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
In Vitro Equinos social profiles
Digital presenceIn Vitro Equinos compliance and trust
Trust signalCompliance2 records
In Vitro Equinos financial estimates
Financial estimateRevenue estimate
Valuation estimate
In Vitro Equinos leadership team
Management profileNumber of profiles
Profiles8 records
In Vitro Equinos subsidiaries and ownership
Company hierarchySubsidiaries4 records
In Vitro Equinos funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
In Vitro Equinos M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about In Vitro Equinos
What does In Vitro Equinos do?
In Vitro Equinos provides advanced equine reproductive biotechnology services for horse breeders and veterinarians, with ICSI (Intracytoplasmic Sperm Injection) as the central commercial offering, complemented by equine cloning via nuclear transfer, genetic banking (cell cryopreservation), embryo biopsy for sex identification, and semen sexing. Services are delivered through a field-and-laboratory model with specialized OPU teams operating on client stud farms and centralized laboratories producing, cryopreserving, and transferring embryos, supported by a proprietary mobile application for real-time client monitoring.
Is In Vitro Equinos a public or private company?
In Vitro Equinos is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was In Vitro Equinos founded?
In Vitro Equinos was founded in 2005. It employs 11 to 50 people.
Where is In Vitro Equinos based?
In Vitro Equinos is headquartered in Mogi Mirim, Brazil, in the Latin America region.
How does In Vitro Equinos make money?
Five revenue lines are on record. ICSI Services are the primary driver. The others are equine Cloning, genetic Bank, embryo Biopsy and semen Sexing.
Who are In Vitro Equinos's main competitors?
Direct peers on record are Crestview Genetics, ViaGen Pets & Equine and Stallion AI Services. Broad incumbents are Rood & Riddle Equine Hospital, IMV Technologies, Hamilton Thorne, Hagyard Equine Medical Institute and Equine Care Group. Equine Reproduction Laboratory (CSU) is listed as an emerging player. Goulburn Valley Equine Hospital is listed as a regional player.
Does In Vitro Equinos have an API?
No public API is recorded for In Vitro Equinos.
What industry is In Vitro Equinos in?
In Vitro Equinos's product category is Equine Reproductive Biotechnology Services. Its primary akta.pro industry code is HLAMABAG, Reproduction, Breeding & Theriogenology (Large Animal/Equine). Its NAICS code is 54194 and its SIC code is 700.